Inhibition of Notch pathway enhances the anti-tumor effect of docetaxel in prostate cancer stem-like cells
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of Notch pathway enhances the anti-tumor effect of docetaxel in prostate cancer stem-like cells
Authors
Keywords
-
Journal
Stem Cell Research & Therapy
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-06-26
DOI
10.1186/s13287-020-01773-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Oncolytic Herpes Simplex Virus and Phosphoinositide 3-kinase Inhibitor BKM120 Synergize to Promote Killing of Prostate Cancer Stem-like Cells
- (2019) Lei Wang et al. Molecular Therapy-Oncolytics
- Stress and stem cells: adult Muse cells tolerate extensive genotoxic stimuli better than mesenchymal stromal cells
- (2018) Nicola Alessio et al. Oncotarget
- Cancer stem cells revisited
- (2017) Eduard Batlle et al. NATURE MEDICINE
- Notch: A multi-functional integrating system of microenvironmental signals
- (2016) Bryce LaFoya et al. DEVELOPMENTAL BIOLOGY
- Prostate cancer
- (2016) Gerhardt Attard et al. LANCET
- Cancer stem cells and chemoresistance: The smartest survives the raid
- (2016) Jihe Zhao PHARMACOLOGY & THERAPEUTICS
- Notch Pathway Inhibition Using PF-03084014, a -Secretase Inhibitor (GSI), Enhances the Antitumor Effect of Docetaxel in Prostate Cancer
- (2015) D. Cui et al. CLINICAL CANCER RESEARCH
- Targeting Notch, Hedgehog and Wnt pathways in cancer stem cells: clinical update
- (2015) Naoko Takebe et al. Nature Reviews Clinical Oncology
- Prostate cancer stem cells: deciphering the origins and pathways involved in prostate tumorigenesis and aggression
- (2015) Adrian P. Rybak et al. Oncotarget
- NOTCH1 signaling promotes chemoresistance via regulating ABCC1 expression in prostate cancer stem cells
- (2014) Cheng Liu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- PSA response rate as a surrogate marker for median overall survival in docetaxel-based first-line treatments for patients with metastatic castration-resistant prostate cancer: an analysis of 22 trials
- (2014) Edoardo Francini et al. TUMOR BIOLOGY
- Expression profiling of stem cell signaling alters with spheroid formation in CD133high/CD44high prostate cancer stem cells
- (2014) GULPERI OKTEM et al. Oncology Letters
- Tumours with elevated levels of the Notch and Wnt pathways exhibit efficacy to PF-03084014, a γ-secretase inhibitor, in a preclinical colorectal explant model
- (2013) J J Arcaroli et al. BRITISH JOURNAL OF CANCER
- Notch signaling pathway targeted therapy suppresses tumor progression and metastatic spread in pancreatic cancer
- (2013) Shinichi Yabuuchi et al. CANCER LETTERS
- Enrichment of Prostate Cancer Stem-Like Cells from Human Prostate Cancer Cell Lines by Culture in Serum-Free Medium and Chemoradiotherapy
- (2013) Lei Wang et al. International Journal of Biological Sciences
- Suppression of Acquired Docetaxel Resistance in Prostate Cancer through Depletion of Notch- and Hedgehog-Dependent Tumor-Initiating Cells
- (2012) Josep Domingo-Domenech et al. CANCER CELL
- Biomarker and Pharmacologic Evaluation of the -Secretase Inhibitor PF-03084014 in Breast Cancer Models
- (2012) C. C. Zhang et al. CLINICAL CANCER RESEARCH
- Targeting Notch to Target Cancer Stem Cells
- (2010) A. Pannuti et al. CLINICAL CANCER RESEARCH
- Evaluation of Selective -Secretase Inhibitor PF-03084014 for Its Antitumor Efficacy and Gastrointestinal Safety to Guide Optimal Clinical Trial Design
- (2010) P. Wei et al. MOLECULAR CANCER THERAPEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now